Pacific Hemostasis FDP (Fibrinogen Degradation Products) Assay Kit (30 Determinations), REF/Model 100650, UDI 00845275000863, IVD; --- Fisher Diagnostics, a division of Fisher Scientific Company LLC ,a part of Thermo Fisher Scientific Inc., Middletown, VA 22645-1905 USA --- For determination of Fibrinogen Degradation products in serum and urine.
Publicado el 2 de agosto de 2017 · Inicio del retiro: 19 de mayo de 2017
Resumen
FDA registra el retiro Z-2762-2017 de dispositivos médicos de Clase II, publicado el 2 de agosto de 2017 e iniciado el 19 de mayo de 2017. Empresa responsable: Fisher Diagnostics; Estado: Finalizado; Cantidad reportada: 331 units; Lote: Lot Number 948546, Exp. 9/30/2017. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While the kit performs accurately at FDP concentrations greater than 20 ¿g/ml, there is an observed reduction in sensitivity when FDP levels are less than 20 ¿g/ml. This reduction in sensitivity has been tied to FDP Latex Reagent lot 890199 and may result in false negatives.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Fisher Diagnostics
- Distribuidor
- USA (nationwide) including Puerto Rico, and Internationally to Colombia
- Lote
- Lot Number 948546, Exp. 9/30/2017
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAPacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time test and factor9 de abril de 2025
- FDAAtrium iCAST Balloon Expandable Covered Stent; 7mm x 22mm x 120cm; Model/Part Number 85455 (Marketed in U.S.2 de agosto de 2017
- FDADLP Antegrade/Retrograde Adapter Method for perfusion of cardioplegia alternately in either an antegrade or2 de agosto de 2017
- FDASmiths Medical CADD Blue-Striped IV Administration Set, REF 21-7036-01, Sterilized using ethylene oxide.2 de agosto de 2017
- FDADLP Cardioplegia Adapter with Pressure Port Provides access for a pressure monitoring needle near the2 de agosto de 2017
- FDAConverters(R) Tiburon(R) Arthroscopy Drape, REF 9414, STERILE EO, Qty. 1, Cardinal Health, Waukegan, IL A2 de agosto de 2017
Preguntas sobre este retiro
¿Pacific Hemostasis FDP (Fibrinogen Degradation Products) Assay Kit (30 Determinations), REF/Model 100650, UDI 00845275000863, IVD; --- Fisher Diagnostics, a division of Fisher Scientific Company LLC ,a part of Thermo Fisher Scientific Inc., Middletown, VA 22645-1905 USA --- For determination of Fibrinogen Degradation products in serum and urine. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2762-2017 el 2 de agosto de 2017. Peligro reportado: An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While the kit performs accurately at FDP concentrations greater than 20 ¿g/ml, there is an observed reduction in sensitivity when FDP levels are less than 20 ¿g/ml. This reduction in sensitivity has been tied to FDP Latex Reagent lot 890199 and may result in false negatives.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter